Reaction profile

The FDA adverse-event record for lymphoplasmacytic enteritis

17 FDA reports name lymphoplasmacytic enteritis, a lower-volume reaction in the CVM extract (VeDDRA 2339). Plate stamps and neighbourhood peers follow.

#2245 of 2,481
by report volume (all reactions)
17
reports citing this reaction
76.5%
death-coded share
Dog
most-affected species
Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Lymphoplasmacytic enteritis has 17 reports now versus 16 in that prior snapshot: 1 more (6.3%).

Report change
+1
Death-coded reports
+1
Death-coded share
+1.5 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Lymphoplasmacytic enteritis changes

FDA AER · VeDDRA plate

Code 2339 VOL-TRACE

VOL-TRACE · DEATH-HOT · BOTTOM-DECILE · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-TRACE 17 reports
  • DEATH-HOT 76.5%
  • BOTTOM-DECILE #2245/2481
  • PHOTO-FINISH Anoestrus
  • SPECIES-DOG Dog · 12
  • DRUG-LEAD Milbemycin Oxime… · 3
  • DESK-WIDE 13 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Anoestrus (±0 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

Lower-volume neighbourhood around Lymphoplasmacytic enteritis

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Anoestrus · near17Bone nonunion, medica… · near17Cardiac insufficiency · near17Cerebral vascular acc… · near17Lymphoplasmacytic ent… · thi…17Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Lymphoplasmacytic enteritis

Lymphoplasmacytic enteritis: high death-coded share in the FDA AER plate

Signature read: Lymphoplasmacytic enteritis's 76.5% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 17 named reports in the openFDA extract. Death-coded share is upper-third: 13 of 17 reports (76.5% of named reports). Nearest volume peer: Anoestrus (±0 reports). Lead species Dog (12). Lead co-reported drug Milbemycin Oxime + Praziquantel (3).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 12
Cat 4
Cattle 1

Breeds Most Affected

Domestic Shorthair 3
Terrier - Yorkshire 2
Havanese 2
Plott 1
Chihuahua 1
Schnauzer - Giant 1
Maine Coon 1
Retriever - Golden 1
Spitz - German Pomeranian 1
Terrier - Bull 1

Associated Drugs

Milbemycin Oxime + Praziquantel 3
Cyclosporine 3
Gabapentin 3
Maropitant Citrate 3
Bedinvetmab 3
Ilunocitinib 3
Lotilaner 2
Robenacoxib 2
Ondansetron 2
Pantoprazole 2
Dexamethasone Sodium Phosphate 2
Enrofloxacin 2
Vitamin B12 2
Oclacitinib Maleate 2
Unspecified Metronidazole 2
Unspecified Maropitant Tablet 2
Protiobic 2
Aminopentamide 2
Unspecified Prednisone 2
Unspecified Furosemide 2

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Lymphoplasmacytic enteritis (#2245 of 2,481 by report volume); death-coded 76.5%. PlainBreed reaction plate · death-coded share stamp 76.5% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →